Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia.
Unlike Escherichia coli strains belonging to phylogroup B2, the clinical significance of strains belonging to phylogroup F is not well understood. Here we report on a collection of phylogroup F strains recovered in Australia from faeces and extra-intestinal sites from humans, companion animals and native animals, as well as from poultry meat and water samples. The distribution of sequence types was clearly non-random with respect to isolate source. The antimicrobial resistance and virulence trait profiles also varied with the sequence type of the isolate. Phylogroup F strains tended to lack the virulence traits typically associated with phylogroup B2 strains responsible for extra-intestinal infection in humans. Resistance to fluoroquinolones and/or expanded-spectrum cephalosporins was common within ST648, ST354 and ST3711. Although ST354 and ST3711 are part of the same clonal complex, the ST3711 isolates were only recovered from native birds being cared for in a single wildlife rehabilitation centre, whereas the ST354 isolates were from faeces and extra-intestinal sites of dogs and humans, as well as from poultry meat. Although ST354 isolates from chicken meat in Western Australia were distinct from all other ST354 isolates, those from poultry meat samples collected in eastern Australia shared many similarities with other ST354 isolates from humans and companion animals.
Evolution, Ecology and Genetics, Research School of Biology, Australian National University, 116 Daley Road, Acton, Australian Capital Territory 2601, Australia.
Belinda
B
Vangchhia
School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia 6150, Australia.
Sam
S
Abraham
Microbiology and Infectious Disease, SA Pathology, Adelaide, South Australia 5000, Australia.
Jan M
JM
Bell
Infectious Disease and Microbiology, Canberra Hospital, Woden, Australian Capital Territory 2606, Australia.|Medical School, Australian National University, Canberra, Australian Capital Territory 0200, Australia.|ACT Pathology, Canberra, Australian Capital Territory, Australia.
Peter
P
Collignon
School of Veterinary Science, University of Queensland, Gatton, Queensland 4343, Australia.
Justine S
JS
Gibson
Department of Microbiology, PathWest, Fiona Stanley Hospital, Perth, Australia.|School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.
Paul R
PR
Ingram
VA Medical Center and Department of Medicine, University of Minnesota, Infectious Diseases (111F), 1 Veterans Drive, Minneapolis, MN 55417, USA.
James R
JR
Johnson
Infectious Disease and Microbiology, Canberra Hospital, Woden, Australian Capital Territory 2606, Australia.|Medical School, Australian National University, Canberra, Australian Capital Territory 0200, Australia.
Karina
K
Kennedy
School of Animal and Veterinary Science, University of Adelaide, Roseworthy, South Australia 5371, Australia.
Darren J
DJ
Trott
Australian Commission on Safety and Quality in Health Care, New South Wales, Australia.|School of Biological Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia.
John D
JD
Turnidge
Evolution, Ecology and Genetics, Research School of Biology, Australian National University, 116 Daley Road, Acton, Australian Capital Territory 2601, Australia.
David M
DM
Gordon
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001315:Australia; D002645:Chickens / Q000382:microbiology; D004285:Dogs / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000145:classification / Q000187:drug effects* / Q000235:genetics* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000382:microbiology* / Q000662:veterinary*; D005243:Feces / Q000382:microbiology; D006801:Humans; D010802:Phylogeny; D014774:Virulence
D000900:Anti-Bacterial Agents